Back | Next |
home / stock / scyx / scyx message board
Subject | By | Source | When |
---|---|---|---|
$SCYX Chart | conix | investorshub | 06/10/2021 6:03:03 PM |
Today is the day! Please no delay on | NoobyDoo | investorshub | 06/01/2021 1:07:47 PM |
A blessed Memorial Day for all that have | NoobyDoo | investorshub | 06/01/2021 12:24:13 AM |
SCYX - SCYNEXIS | Run22222 | investorshub | 05/26/2021 6:31:07 PM |
So exciting -> $IMO the After Hrs | GMA13 | investorshub | 01/01/2021 4:57:55 PM |
We are sitting on a potentially a gold | GMA13 | investorshub | 01/01/2021 4:33:54 PM |
Insiders started loading this one up on 12/21! | mr2d2 | investorshub | 12/23/2020 2:43:55 PM |
SCYNEXIS Announces FDA Acceptance and Priority Review of | Alyssa | investorshub | 12/07/2020 5:14:48 PM |
Average price target $31.25 - In the last | Alyssa | investorshub | 11/23/2020 8:17:21 PM |
It should pop of shortly. Picking up shares | Foontik1 | investorshub | 10/21/2020 1:22:46 PM |
Something is going on! I am in. GLTA | sabadollar | investorshub | 10/08/2020 5:39:11 PM |
I closed the books on this pile of | dabonenose | investorshub | 07/16/2020 10:34:31 PM |
$SCYX plans on holding an investor event on | GMA13 | investorshub | 07/13/2020 12:31:52 AM |
I received a thank you & was also | GMA13 | investorshub | 06/23/2020 1:09:41 AM |
$IMO but not to Advise: | GMA13 | investorshub | 06/23/2020 12:21:08 AM |
And your response was...... | dabonenose | investorshub | 05/17/2020 4:12:31 PM |
znewcar1: SCYX 7% v2M C1.15 f97M H1.19 twice as much float and 3/4 the price had some good vol last | znewcar1 | investorshangout | 02/20/2020 2:31:44 AM |
znewcar1: 25% v2,6M c1.58 f47,971,673 H1.61 nice bull flag. | znewcar1 | investorshangout | 03/14/2019 8:54:42 PM |
znewcar1: 41.67% v27,443,301 c1.020000 47,971,673 Open 1.3 and fell all day | znewcar1 | investorshangout | 01/31/2019 10:14:04 PM |
znewcar1: 2019-0107 25.26% 1,003,296 .768500 47,971,673 | znewcar1 | investorshangout | 01/19/2019 7:08:38 PM |
News, Short Squeeze, Breakout and More Instantly...
JERSEY CITY, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that it will receive a $10 million development milestone payment un...